Related references
Note: Only part of the references are listed.Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
Helen E. White et al.
LEUKEMIA (2022)
Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia
Dawne N. Shelton et al.
PLOS ONE (2022)
Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start?
Maria Teresa Bochicchio et al.
CANCERS (2021)
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia
Georg-Nikolaus Franke et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts
Jessica Petiti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020
Jim F. Huggett et al.
CLINICAL CHEMISTRY (2020)
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
Simona Soverini et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice
Camille C. B. Kockerols et al.
HEMASPHERE (2020)
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?
Camilla Zanaglio et al.
CASE REPORTS IN ONCOLOGY (2020)
Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials
Birgit Spiess et al.
PLOS ONE (2019)
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay
Lasse Kjaer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay. Is dPCR the key?
Simona Bernardi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
New approaches to molecular monitoring in CML (and other diseases)
Jerald Radich et al.
BLOOD (2019)
Optimized Digital Droplet PCR for BCR-ABL
Jacqueline Maier et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia
Mary Alikian et al.
CLINICAL CHEMISTRY (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale
N. C. P. Cross et al.
LEUKEMIA (2016)
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization
Nicholas C. P. Cross et al.
ANNALS OF HEMATOLOGY (2015)
Detection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR
Lawrence J. Jennings et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
Helen E. White et al.
BLOOD (2010)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
Share Paper
